Amcor plc (AMCR) is significantly drawing attention due to its potential to be the preeminent ASX dividend stock heading into 2025 and as a value and sustainable dividend stock considering the estimated 17% returns on equity. The company has widely attracted interest from
institutional investors, owning about 63% of the company. Critical changes in the board of directors have also been announced.
Fiscal 2024 highlighted robust growth in core businesses, but earnings have missed analyst estimates. This situation elicits questions on whether investing in this stock is advisable. One aspect shining brightly on Amcor's canvas is a
merger with Berry Global, potentially escalating growth and creating a global leader in consumer and healthcare packaging solutions. However, a fall in stock price by 7.86% on Nov 1, instigated doubtfulness since institutional owners favoured 64% of the company. Strangely, some reports suggest AMCR is the worst Dividend Aristocrat stock to buy. The fluctuating market performance of Amcor demonstrates a mix of strong value and medium-term momentum. The Q1 2025 earnings call transcript indicates a decrease in revenues by 2.6% Y/Y, raising concerns despite meeting estimates.
Amcor Plcs AMCR News Analytics from Fri, 20 Sep 2019 21:15:30 GMT to Fri, 27 Dec 2024 10:15:08 GMT -
Rating 3
- Innovation -2
- Information 6
- Rumor -2
